|Company name||U.S. Physical Therapy, Inc.|
|Live stock price||[stckqut]USPH[/stckqut]|
|P/E compared to competitors||Fair|
|Confident Investor Rating||Fair|
|Target stock price (TWCA growth scenario)||$16.72|
|Target stock price (averages with growth)||$24.12|
|Target stock price (averages with no growth)||$22.88|
|Target stock price (manual assumptions)||$19.6|
The following company description is from Google Finance: http://www.google.com/finance?q=usph
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company also operates two clinics, which specialize in the outpatient, non-surgical treatment of osteo arthritis degeneration joint disease and other musculoskeletal conditions. It primarily operates through subsidiary clinic partnerships in which it generally owns a 1% general partnership interest and a 64% limited partnership interest and the managing therapist(s) of the clinics owns the remaining limited partnership interest in the majority of the clinics (referred to as Clinic Partnerships). In March 2010, the Company acquired a 70% interest in a five clinic outpatient physical therapy group. In July 2011, the Company acquired 20 clinic physical therapy group.
Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.